NPR's A Martinez speaks with journalist Mark Medley about his new book, "Live to see the Day," an exploration of people motivated by nearly impossible goals.

Google recently published a guide outlining eight essential design patterns for multi-agent systems, ranging from sequential ...

Microsoft has cut its sales targets for its agentic AI software after struggling to find buyers interested in using it. In some cases, targets have been slashed by up to 50%, suggesting Microsoft ...

AT&T (T) chief executive John Stankey will speak at Tuesday’s UBS Global Media & Communications Conference where he will discuss the company’s network and financial outlook. This transaction is ...

SUNRISE, Fla. --Sam Bennett scored with four seconds remaining in overtime, and the Florida Panthers ended their four-game losing streak by rallying for a 7-6 win against the Columbus Blue Jackets at ...

Brandon Aubrey has had some impressive games in his career, but he might have outdone himself on Thursday night in Detroit. The kicker broke two NFL records against the Lions and he was one of the few ...

After Alabama’s commanding 56-0 victory over Eastern Illinois, perhaps the biggest storylines in the SEC grew even more as another Conor Talty kick did not go through the uprights. The fans in ...

Contineum Therapeutics (CTNM) shares fell following the results from its mid-stage trial of PIPE-307, a treatment aimed at patients with relapsing-remitting multiple sclerosis. The trial did not ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) on Thursday shared topline data from its Phase 2 VISTA trial of PIPE-307, an M1 receptor antagonist for relapsing-remitting multiple sclerosis (RRMS). RRMS ...

Roche said its fenebrutinib drug candidate met primary goals in two late-stage trials for multiple sclerosis, reducing attacks or delaying disability progression in two different forms of the disease.